Arcellx (NASDAQ:ACLX – Get Rating) had its price objective cut by Truist Financial from $60.00 to $57.00 in a research note published on Tuesday morning, The Fly reports. Several other analysts have also recently commented on the company. HC Wainwright boosted their price target on Arcellx from $40.00 to $49.00 in a research report on […]
Arcellx (NASDAQ:ACLX – Get Rating) and Mosaic ImmunoEngineering (OTCMKTS:CPMV – Get Rating) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, earnings, valuation and risk. Institutional & Insider Ownership 91.8% of Arcellx shares are held by […]
Arcellx, Inc. (NASDAQ:ACLX – Get Rating) insider Rami Elghandour sold 2,600 shares of the stock in a transaction on Wednesday, May 31st. The stock was sold at an average price of $44.27, for a total value of $115,102.00. Following the sale, the insider now owns 36,169 shares in the company, valued at approximately $1,601,201.63. The […]
Arcellx, Inc. (NASDAQ:ACLX – Get Rating) CFO Michelle Gilson sold 8,704 shares of the business’s stock in a transaction dated Wednesday, May 24th. The stock was sold at an average price of $42.46, for a total value of $369,571.84. Following the sale, the chief financial officer now owns 15,485 shares in the company, valued at […]
Arcellx, Inc. (NASDAQ:ACLX – Get Rating) shares fell 2.6% during mid-day trading on Friday after an insider sold shares in the company. The stock traded as low as $40.14 and last traded at $41.69. 46,686 shares were traded during mid-day trading, a decline of 90% from the average session volume of 472,636 shares. The stock […]